重庆医学2025，Vol.54Issue(3)：760-764,5.DOI:10.3969/j.issn.1671-8348.2025.03.035
T2型哮喘相关生物标志物的研究进展
Research advances in T2-type asthma biomarkers
摘要
Abstract
Asthma,one of the most prevalent chronic immune disorders worldwide,is classified into type 2(T2)and non-T2 asthma based on airway inflammation patterns.Patients with different phenotypes ex-hibit variations in clinical manifestations,disease severity,and therapeutic sensitivity.Currently,various treat-ment modalities including biologics have been developed for refractory asthma,most demonstrate better thera-peutic responses in T2 asthma.This highlights the critical importance of timely and accurate identification of T2 asthma and assessment of its severity through highly specific and sensitive biomarkers,which can guide precision treatment strategies to enhance therapeutic efficacy and reduce economic burdens.This article sum-marizes recent advancements in T2 asthma-related biomarkers to provide references for precision diagnosis and personalized treatment.关键词
T2型哮喘/生物标志物/表观遗传学/评估Key words
type 2 asthma/biomarkers/epigenetics/evaluation分类
医药卫生引用本文复制引用
刘海琴,唐昊..T2型哮喘相关生物标志物的研究进展[J].重庆医学,2025,54(3):760-764,5.基金项目
国家自然科学基金项目(82070036). （82070036）
